Quest Diagnostics Inc. (DGX)
-NYSE 61.97 
0.85(1.39%) 04:02 SGT
| Prev Close: | 61.12 |
|---|
| Open: | 60.77 |
|---|
| Bid: | 61.87 x 200 |
|---|
| Ask: | 62.98 x 100 |
|---|
| 1y Target Est: | 59.50 |
|---|
| Beta: | 0.85 |
|---|
| Next Earnings Date: | 15-Jul-13 |
|---|
| Day's Range: | 60.69 - 62.07 |
|---|
| 52wk Range: | 53.25 - 64.87 |
|---|
| Volume: | 1,116,784 |
|---|
| Avg Vol (3m): | 1,376,250 |
|---|
| Market Cap: | 9.79B |
|---|
| P/E (ttm): | 18.70 |
|---|
| EPS (ttm): | 3.31 |
|---|
| Div & Yield: | 1.20 (2.00%) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Today's Stocks Driving Success For The Health Services Industryat TheStreet(Fri, 01:03 SGT)
- 5 Dividend Stocks Boasting High Free Cash Flow Yieldsat Motley Fool(Thu, 23 May)
- Medicare Nixes Coverage For New Cancer Testsat Forbes(Wed, 22 May)
- Quest Diagnostics Keeps Dividend Levelat Motley Fool(Wed, 22 May)
- Daily Dividend Report: XRX, DGX, DKS, UVV, AWRat Forbes(Wed, 22 May)
- Quest Diagnostics Declares Quarterly Cash DividendPR Newswire(Wed, 22 May)
- Thermo Fisher A Decent Long-Term Opportunityat Seeking Alpha(Tue, 21 May)
- Activist investor wants Alere to explore $2.5 billion unit sale: sourcesat Reuters(Tue, 21 May)
- Humana selling Concentra lab businessAP(Fri, 17 May)
- Analysis - Ahead of reform, medical care slowdown hits U.S. companiesReuters(Mon, 22 Apr)
Key Statistics
| Forward P/E (1 yr): | 12.88 |
|---|
| P/S (ttm): | 1.33 |
|---|
| Ex-Dividend Date: | 28-Mar-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 4.35 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.10 |
|---|
| Mean Recommendation*: | 3.0 |
|---|
| PEG Ratio (5 yr expected): | 1.35 |
|---|
Business Summary
Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions.
View More